Renovaro Biosciences Inc. (RENB)
Market Cap | 238.59M |
Revenue (ttm) | n/a |
Net Income (ttm) | -53.93M |
Shares Out | 153.93M |
EPS (ttm) | -0.78 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 341,115 |
Open | 1.530 |
Previous Close | 1.560 |
Day's Range | 1.480 - 1.570 |
52-Week Range | 0.421 - 5.250 |
Beta | 0.44 |
Analysts | n/a |
Price Target | n/a |
Earnings Date | May 15, 2024 |
About RENB
Renovaro Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), and cancer in the United States. The company's product pipeline includes RENB-HV-01 for autologous HIV curative treatment; RENB-HV-12, a therapeutic HIV vaccine; and RENB-HB-01, a gene therapy curative treatment for HBV. It also develops RENB-DC-11, an allogeneic dendritic cell therapeutic vaccine for pancreatic cancer;... [Read more]
Financial Performance
Financial StatementsNews
![](https://cdn.snapi.dev/images/v1/c/p/press6-2479749.jpg)
Renovaro, Inc. Announces $10 million in Equity Committed
LOS ANGELES, June 14, 2024 (GLOBE NEWSWIRE) -- Renovaro, Inc. (NASDAQ: RENB) (the “Company”) announces that it has $10 million in additional equity committed at a price per share of $1.4726 and 10 per...
![](https://cdn.snapi.dev/images/v1/m/e/press15-2447191.jpg)
Renovaro Inc. and Amsterdam UMC Cancer Center Poised to Advance Cancer Immunotherapy
LOS ANGELES and AMSTERDAM, May 24, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB) and the Amsterdam UMC Cancer Center today announced an intended partnership and therefore signed an MoU to esta...
![](https://cdn.snapi.dev/images/v1/v/l/medical-examination-and-health-2441449.jpeg)
Top 5 Health Care Stocks Which Could Rescue Your Portfolio This Month - Renovaro (NASDAQ:RENB)
The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
![](https://cdn.snapi.dev/images/v1/j/x/press9-2400335.jpg)
Transforming Cancer Detection: RenovaroCube Introduces Flamingo, a novel AI model based on Fragmentomics
LOS ANGELES and AMSTERDAM, April 30, 2024 (GLOBE NEWSWIRE) -- RenovaroCube, wholly owned subsidiary of Renovaro, Inc. (Nasdaq: RENB), a company at the forefront of AI-driven healthcare innovation, pro...
![](https://cdn.snapi.dev/images/v1/q/5/press13-2388056.jpg)
RenovaroCube to Acquire 100% Ownership of Cyclomics, Reinforcing Cutting-Edge Cancer Diagnostics Partnership
LOS ANGELES and AMSTERDAM, April 24, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (Nasdaq: RENB), a trailblazer in AI-driven early cancer diagnostics and therapeutics, and Cyclomics, a leader in ultra-sensi...
![](https://cdn.snapi.dev/images/v1/q/9/press10-2378143.jpg)
Renovaro Inc. Proudly Announces the Appointment Of Professor Dr. Geert Kazemier as the Chairman of its Scientific Advisory Board, A Move That Heralds a New Era of Innovation and Progress in its Mission to Reshape Cancer Screening, Diagnosis, and Patient Care
LOS ANGELES and AMSTERDAM, April 18, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (Nasdaq: RENB), a pioneer in cancer diagnostics and therapeutics powered by artificial intelligence, announces the distingui...
![](https://cdn.snapi.dev/images/v1/p/a/press7-2319069.jpg)
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Renovaro Biosciences Inc. - RENB
NEW YORK, March 11, 2024 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Renovaro Biosciences Inc. ("Renovaro" or the "Company") (NASDAQ: RENB). Such investors are adv...
![](https://cdn.snapi.dev/images/v1/m/e/press18-2292575.jpg)
ROSEN, LEADING INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB
NEW YORK , Feb. 25, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Renovaro Biosciences ...
![](https://cdn.snapi.dev/images/v1/b/5/press11-2281300.jpg)
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation - RENB
NEW YORK , Feb. 16, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Renovaro Bioscie...
![](https://cdn.snapi.dev/images/v1/d/e/press1-2278209.jpg)
Cutting Edge AI Company GEDiCube and Cyclomics sign binding LOI to join forces and position themselves at the forefront of the global liquid biopsy marketplace
The combined Companies aim to Disrupt Cancer Diagnosis and treatment through early disease and recurrence detection, prediction of response to treatment, and personalized therapy.
![](https://cdn.snapi.dev/images/v1/k/v/press7-2275907.jpg)
Statement of Renovaro Inc
LOS ANGELES, Feb. 14, 2024 (GLOBE NEWSWIRE) -- The following is a statement by Renovaro (Nasdaq: RENB) in response to Hindenburg's recent opinion piece:
![](https://cdn.snapi.dev/images/v1/h/v/press11-2274282.jpg)
ROSEN, A LEADING NATIONAL FIRM, Encourages Renovaro Biosciences Inc. Investors to Inquire About Securities Class Action Investigation – RENB
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Renovaro Biosciences Inc. (NAS...
![](https://cdn.snapi.dev/images/v1/w/t/press5-2273574.jpg)
AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicine
LOS ANGELES, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB) announced today that it completed its acquisition of GEDi Cube Intl Ltd. (“GEDiCube”). Renovaro, which means renew, combines...
![](https://cdn.snapi.dev/images/v1/i/z/press16-2245189.jpg)
Renovaro Biosciences Announces Results of Special Meeting of Shareholders
LOS ANGELES, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. (NASDAQ: RENB) (the “Company”), a biotechnology corporation focusing on cell, gene, and immunotherapy, announced today the resu...
![](https://cdn.snapi.dev/images/v1/j/w/press3-2230253.jpg)
Message from Renovaro Bioscience, Inc.'s CEO, The Hon. Mark Dybul, MD
Accelerating Healthcare With Award-Winning AI: Big Steps Forward In 2023 And The Early Days Of 2024 Accelerating Healthcare With Award-Winning AI: Big Steps Forward In 2023 And The Early Days Of 2024
![](https://cdn.snapi.dev/images/v1/m/r/press13-2224892.jpg)
RENOVARO BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Renovaro Biosciences Inc. - RENB
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Renovaro Biosc...
![](https://cdn.snapi.dev/images/v1/s/s/press7-2098819.jpg)
Avram Miller, Co-Founder of Intel Capital, Joins Renovaro Biosciences Board of Directors
LOS ANGELES, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. (NASDAQ: RENB)(Renovaro), a biotechnology corporation focusing on cell, gene, and immunotherapy, has announced that Avram Mille...
![](https://cdn.snapi.dev/images/v1/9/d/press1-2096541.jpg)
Renovaro Biosciences Appoints Two Finance Industry Experts to Board of Directors
LOS ANGELES, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. (NASDAQ: RENB)(Renovaro), an advanced, pre-clinical biotechnology firm in cell, gene, and immunotherapy focused on solid tumors...
![](https://cdn.snapi.dev/images/v1/i/m/press15-2086227.jpg)
Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD
AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine
![](https://cdn.snapi.dev/images/v1/f/z/press19-2085856.jpg)
AI Company GEDiCube and Renovaro Biosciences Sign Definitive Agreement to Combine
Message from Renovaro Biosciences CEO, The Hon. Mark Dybul, MD LOS ANGELES, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Renovaro Biosciences Inc. (Nasdaq: RENB) Dear Shareholders, I am writing to provide you wi...
![](https://cdn.snapi.dev/images/v1/p/7/press13-2083874.jpg)
RENB Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Renovaro Biosciences Inc. Is Fair to Shareholders
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Renovaro Biosciences Inc. (NASDAQ: RENB) and GEDi Cube Intl Ltd. is fair to Renovaro sh...
![](https://cdn.snapi.dev/images/v1/x/8/press3-2083665.jpg)
Renovaro Biosciences and AI Health Company GEDi Cube Sign Definitive Agreement to Combine
The combined company aims to accelerate precision, personalized medicine for longevity powered by mutually reinforcing AI and biotechnology platforms for early diagnosis, better targeted treatments, a...
![](https://cdn.snapi.dev/images/v1/b/5/press14-2083675.jpg)
GEDi Cube and Renovaro Biosciences Sign Definitive Agreement to Combine
LOS ANGELES & AMSTERDAM--(BUSINESS WIRE)--GEDi Cube Intl Ltd. (GEDi Cube), an AI medical technology company, and Renovaro Biosciences Inc. (NASDAQ:RENB) (Renovaro), an advanced, preclinical biotechnol...
![](https://cdn.snapi.dev/images/v1/q/r/press4-2043069.jpg)
Renovaro BioSciences Welcomes GEDiCube Announcement of New Joint Effort
LOS ANGELES, Aug. 30, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RENB). Renovaro BioSciences congratulates GEDiCube on their joint effort to work to accelerate early diagnosis of cancer in clinical trials.
![](https://cdn.snapi.dev/images/v1/g/p/press5-2030658.jpg)
Renovaro BioSciences Congratulates GEDi Cube on Appointment of its Chief Medical Officer
LOS ANGELES, Aug. 21, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RENB). Renovaro BioSciences congratulates GEDi Cube on its appointment of Dr. Lester Russell as Chief Medical Officer. For more information: (ht...